Delivery Order SPE2DB24D3015-SPE2DB25FGAGH
- Not listed
- This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, is a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical valued at $2,184.76. The award is for the supply of 4,564,222,202 units of Hydromorphone HCL ER 8 mg tablets in 100-count bottles. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA, which...
- This is a delivery order worth $1,481.33 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order is for hydromorphone hydrochloride extended-release 16 mg tablets, a critical pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,711.56, is for the delivery of 4566355165 Hydromorphone HCL ER 8 mg tablets in 100-count bottles. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and...
- The Defense Logistics Agency awarded a delivery order valued at $2,127.10 to AmerisourceBergen Drug Corp for Hydromorphone 1 mg/ml, a controlled pharmaceutical used in pain management and palliative care. Issued on July 21, 2025, with an ultimate completion date of July 22, 2025, this firm fixed-price delivery order was competitively awarded without set-aside designation. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567828961 HYDROMORPHONE HCL ER 8 MG TAB 100S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,249.59 and an ultimate completion date of April 8, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $3,293.31 contract is for the delivery of 100 units of Hydromorphone HCL ER 16 mg tablets. This order supports DLA Troop Support Medical's program to provide pharmaceuticals and critical care supplies to military treatment facilities. Amerisourcebergen Drug Corp has received...
- The Defense Logistics Agency Troop Support Medical awarded a $1,249 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561412959 Hydromorphone HCl ER 8 mg tablets. The prime contractor will deliver 100 tablets to its place of performance in Conshohocken, Pennsylvania by July 6, 2023 to fulfill requirements under an indefinite-delivery/indefinite-quantity contract vehicle. As a component of the Department of Defense, the Defense Logistics Agency supports America's armed...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The award, valued at $4,010.30, is for the supply of hydromorphone hydrochloride extended-release 16 mg tablets in quantities of 100. The delivery order was issued under an indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp by...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The $8,603.00 Firm Fixed Price Delivery Order is for the supply of hydromorphone hydrochloride extended-release 16 mg tablets. The award appears to be under a larger Indefinite Delivery Contract (IDC) vehicle that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Hydromorphone HCL ER 16 MG Tablets, a pain management medication, with a ceiling value of $18,421.30. The delivery order is a firm fixed price contract with a period of performance that runs through July 10, 2025. The contract is not designated as a set-aside and was...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB25FGAGHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,348.21 to AmerisourceBergen Drug Corp for Hydromorphone HCL ER 8 mg tablets (100-count supply) with a completion date of July 28, 2025. This contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is fulfilling this order from its corporate office location. This delivery order represents one of many pharmaceutical procurement actions issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of medications and medical supplies to support military and veteran healthcare systems. AmerisourceBergen's substantial federal contract portfolio with the Defense Logistics Agency demonstrates its critical role in ensuring consistent pharmaceutical availability across the Department of Defense medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/25/25 |